We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About GT Medical Technologies Stock

Invest in or calculate the value of your shares in GT Medical Technologies or other pre-IPO companies through EquityZen's platform.

Get Started

GT Medical Technologies Stock (GTMT)

GT Medical Technologies provides surgically targeted radiation therapy to individuals with operable brain tumors.

About GT Medical Technologies Stock

Founded

2017

Headquarters

Tempe, AZ, US

Industries

Software, Data and Analytics, Artificial Intelligence

GT Medical Technologies, an Arizona-based medical device company, is focused on improving the lives of patients with brain tumors. GT has developed an innovative approach to treatment by combining a conformable collagen matrix with brachytherapy (radiation) seeds. The company's first product, GammaTile™ is protected by 10 US and 2 Canadian-issued patents, and 1 EPO patent. The product has the promise to revolutionize treatment for 176,000 patients/year in the US alone. To date, we have treated 120 patients with recurrent brain tumors in a clinical trial at Barrow Neurological Institute (BNI) and observed significant clinical improvement.

GT Medical Technologies Management

Leadership team at GT Medical Technologies

Vice President Marketing

Jane Steen

Vice President Clinical Affairs

Lisa Misell

Locked Features

Join now and verify your accreditation status to gain access to:

  • GT Medical Technologies current valuation
  • GT Medical Technologies stock price
  • Available deals in GT Medical Technologies and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

How to invest in GT Medical Technologies stock?

Accredited investors can buy pre-IPO stock in companies like GT Medical Technologies through EquityZen funds. These investments are made available by existing GT Medical Technologies shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell GT Medical Technologies stock?

Shareholders can sell their GT Medical Technologies stock through EquityZen's private company marketplace. EquityZen's network includes over 320K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 42K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."